The investigators focused on how the disease emerged in the last 30 years and have tried to match chemical exposures to this time line and have come up with Monsanto's herbicide, Round-Up.
Here is the pubmed listing for the investigation
Holy Mackerel! This week we will discuss fish oil use in maintenance hemodialysis patients. Could this be the one thing that bends the curve on CV mortality, or is it just a red herring?
This week, we will discuss the phase 3 ORIGIN3 trial of atacicept, an APRIL/BAFF inhibitor for use in IgAN.
Day 3 of Kidney Week. Sibeprenlimab and Balcinrenone on NEJM and Lancet, plus a couple of other non-kidneywk studies.
in this edition: Fish Oil, GBD, Flozination meta-analysis, CHW intervention in Hispanic/Latino patients, and much more
The investigators focused on how the disease emerged in the last 30 years and have tried to match chemical exposures to this time line and have come up with Monsanto's herbicide, Round-Up.
Here is the pubmed listing for the investigation
An RCT in Hemodialysis patients that is positive? Where do I sign up!
Spironolactone Reduces Cardiovascular and Cerebrovascular Morbidity and Mortality in HD Patients http://t.co/VgPvhrLcS7 potential 4 #NephJC
— Matt Sparks (@Nephro_Sparks) July 10, 2014
Think JACC would make this open access?
Just after we finished the Mesoamerican Nephropathy twitter chat I received the following e-mail:
What a great comment. We usually measure success by the number of people that engage in the conversation but there is another group of people who listen without talking. Great to hear from one of them to remind us that there are multiple ways to get value from NephJC.
The editors of Nature Reviews Nephrology were some of NephJC's earliest supporters. One of the ways they supported us was by suggesting an article for discussion. We decided to use that article and they even made that article open access. This is a limited time offer so make sure you run over to their site and download the study. We are so appreciative of all the support the crew at Nature Reviews Nephrology has offered NephJC. Thank-you guys.
We will be discussing this interesting Perspective on Twitter at 9PM Eastern on Tuesday July 8. Use hashtag #NephJC.
This was a a game of one-on-one with Topf interviewing lead author Somjot Brar
NephJC will be doing a live Google Hangout tonight, Tuesday at 9pm EDT. We will have Somjot Brar, the lead author of POSEIDON and Peter McCullough cardiologist and expert on contrast nephropathy joining Joel Topf.
We will try to take questions from people watching, so tweet your questions with the hashtag #NephJC and we will forward them on to our panel of experts.
At the end of the discussion we will announce the next NephJC article.
Last week in the e-mail announcement for the TweetChat we had a trivia contest. We asked what has more sugar, a lightly sweetened cup of coffee or all of the plasma in all of the body of an euglycemic adult?
Almost immediatly we got the following tweet:
@NephJC 70kg male’s PV=3.5l*plasma glu 5mmol/l =17.5mmol glu. 0.0175 moles *180.15(molar mass of glucose)=3.1g. Sachet of sugar contains 4g!
— Eoin O Sullivan (@OThebadpenny) June 24, 2014
Which is correct! Eoin will be enjoying his lightly sweetened coffee from a new NephJC coffee mug just as soon as the boat delivers it across the pond. Congratulations Eoin!
This is an overview of the overall discussion - given the fascinating dialogue, we will follow up with another version soon.
Tejas Desai continues to step up to summarize our journal clubs.
We just finished the latest NephJC and it was awesome. We had the most people and the most tweets we have ever had in a one hour TweetChat. A big thanks to everybody that participated.
Please send your suggestions for future NephJCs to NephrologyJC@gmail.com
The wrap up post of the hyponatremia guideline discussion is posted as a comment on all three versions of the guidelines on Pubmed here.
This study dropped a couple of weeks ago and we pushed up the list to go next week on NephJC.
Possible #NephJC article POSEIDAN rct for the prevention of contrast nephropathy. http://t.co/uzIldeZqqg
— Joel Topf (@kidney_boy) May 30, 2014
POSEIDAN: during a cardiac cath you can measure LV end-diastolic pressure, (1/2) pic.twitter.com/ukxk5uf2nV
— Joel Topf (@kidney_boy) May 30, 2014
POSEIDAN (2/2) so pts randomized to using LVEDP data (or not) to guide hydration. pic.twitter.com/Ln86fA6SLJ
— Joel Topf (@kidney_boy) May 30, 2014
POSEIDAN… and it works. pic.twitter.com/McEeGI1dNq
— Joel Topf (@kidney_boy) May 30, 2014
Look for a full introduction on the NephJC home page in the next couple of days.
Programming Note: due to the fact that I want to remain married, we will be changing the date of the next #NephJC from Tuesday to Wednesday June 25th due to my 14th wedding anniversary.
We had a great discussion tonight with Joel and Swapnil being joined by the Dean of Sodium, Dr. Richard Sterns of the University of Rochester and Dr. Hatim Hassam of the University of Chicago. Check it out.
Marco won our contest by signing up for the NephJC Newsletter. We expect nephrology efficiency in Bogota to sky rocket.
I have the mug power !! #NephJC pic.twitter.com/B3ebdtkESA
— Nefrotweet (@Nefrotweet) June 13, 2014
Though there are no mugs on the line, please sign up for our newsletter so you don't miss any NephJC activities.
He does a nice job editing the discussion from 270 tweets to a bare minimum 54.